Visitors to date

 
 
Product's website
 
Internal    Pharmaceuticals firm releases diabetes meds ()

BINH DUONG — Local drug company ICA Pharmaceuticals has introduced new medicines to treat diabetes and complications associated with the condition onto the Vietnamese market.

One of the medicines is Zidenol (Gliclazide) which can be used to treat type 2 diabetes. The other is Zidimet (Trimetazidine) which is suitable for sufferers of coronary thrombosis.

The medicines would cost 15-20 per cent less than similar imported products and would be manufactured to European standards, ICA said.

The wholly locally-invested company launched the medicines last Saturday at a meeting of several hundred professors, doctors and experts in the southern province of Binh Duong.

Diabetes is on the rise in Viet Nam, according to research from HCM City’s health department.

About 5 per cent of the city’s adults suffer from diabetes and more than three-quarters of these patients later develop cardio-arterial diseases it said. — VNS

(Source VietNam News)


 Please select other news
Resolution Board of Dirtectors 03/2016 (05/03/2016)
Extraordinary General Shareholders' Meeting 2015 (17/11/2015)
Adagrin, Tobicom, Coxlec, Fortec, Victron (Apr 05, 2011)
Adagrin (Nov 30, 2010)
ICA attended the conference investment direction in the field of pharmaceuticals towards 2020 (Jul 30, 2010)
Liponil 10 - Treatment of hypercholesterolemia (Oct 21, 2010)
Perpetual ownership of the brand “TOBICOM” by ICA Biotechnological - Pharmaceutical JSC in Vietnam (Jul 26, 2010)
Resolution of 2010 Annual General Meeting of Shareholders (Jul 20, 2010)
Free trip to HongKong (May 27, 2010)
Closing of the list of Shareholders to be paid dividends of 2009 and Annual General Meeting of Shareholders in 2010 (May 20, 2010)

Home page  |  About us  |  Products  |  News  |  Career  |  Sitemap
Lot 10, Street 5, VSIP, Binh Duong, Viet Nam. Tel: +84 (650) 3757922 - Fax: +84 (650) 3757921 - Email: info@icapharma.com
Copyright © 2010 ICA® JSC. All rights reserved.